Krystal Biotech (KRYS) News Today $168.91 +3.91 (+2.37%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Abeona Therapeutics: An Uncertain Pivotal Regulatory Catalyst With Limited Long-Term UpsideApril 14 at 11:03 AM | seekingalpha.comKrystal Biotech, Inc. (NASDAQ:KRYS) Shares Bought by Evolutionary Tree Capital Management LLCEvolutionary Tree Capital Management LLC raised its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 17.4% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 10,700 shares of the company's stock afterApril 14 at 7:28 AM | marketbeat.comCenterBook Partners LP Buys Shares of 4,283 Krystal Biotech, Inc. (NASDAQ:KRYS)CenterBook Partners LP bought a new stake in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 4,283 shares of the company's stock, valued at approxiApril 14 at 5:30 AM | marketbeat.comBrokerages Set Krystal Biotech, Inc. (NASDAQ:KRYS) PT at $220.00April 14 at 2:19 AM | americanbankingnews.comKrystal Biotech, Inc. (NASDAQ:KRYS) Receives Average Recommendation of "Buy" from AnalystsKrystal Biotech, Inc. (NASDAQ:KRYS - Get Free Report) has been assigned an average recommendation of "Buy" from the eight ratings firms that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating, six have issued a buy rating and one has iApril 13 at 3:31 AM | marketbeat.comExodusPoint Capital Management LP Buys Shares of 9,761 Krystal Biotech, Inc. (NASDAQ:KRYS)ExodusPoint Capital Management LP bought a new stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 9,761 shares of the company's stock, valued at approximately $1,529,000. Other largeApril 12 at 4:52 AM | marketbeat.comJPMorgan Chase & Co. Buys 23,934 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)JPMorgan Chase & Co. grew its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 18.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 151,835 shares of the company's stock afterApril 12 at 3:59 AM | marketbeat.comFmr LLC Increases Position in Krystal Biotech, Inc. (NASDAQ:KRYS)Fmr LLC grew its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 0.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,314,014 shares of the company's stock after purApril 11 at 5:45 AM | marketbeat.comOLD Mission Capital LLC Buys Shares of 1,868 Krystal Biotech, Inc. (NASDAQ:KRYS)OLD Mission Capital LLC bought a new position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 1,868 shares of the company's stock, valued at aApril 9, 2025 | marketbeat.comKrystal Biotech, Inc.: Jeune Aesthetics Appoints Marc Forth as Chief Executive OfficerApril 8, 2025 | finanznachrichten.deKrystal Biotech’s Jeune Aesthetics names Marc Forth as CEOApril 8, 2025 | markets.businessinsider.comAnalysts Issue Forecasts for Krystal Biotech Q1 EarningsApril 8, 2025 | americanbankingnews.comKrystal Biotech Q1 EPS Forecast Reduced by William BlairKrystal Biotech, Inc. (NASDAQ:KRYS - Free Report) - Analysts at William Blair reduced their Q1 2025 EPS estimates for Krystal Biotech in a research report issued to clients and investors on Wednesday, April 2nd. William Blair analyst S. Corwin now anticipates that the company will post earnings pApril 8, 2025 | marketbeat.comJeune Aesthetics Appoints Marc Forth as Chief Executive OfficerApril 7, 2025 | globenewswire.comRhenman & Partners Asset Management AB Buys 6,750 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Rhenman & Partners Asset Management AB grew its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 39.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 23,750 shares of the company's stock after purchasing an additionaApril 7, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by Headlands Technologies LLCHeadlands Technologies LLC reduced its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 76.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,635 shares of the company's stock afterApril 7, 2025 | marketbeat.comFranklin Resources Inc. Reduces Position in Krystal Biotech, Inc. (NASDAQ:KRYS)Franklin Resources Inc. decreased its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 24.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 184,027 shares of the company's stocApril 7, 2025 | marketbeat.comNorges Bank Purchases New Position in Krystal Biotech, Inc. (NASDAQ:KRYS)Norges Bank acquired a new stake in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 219,528 shares of the company's stock, valued at approximately $34,391,000. Norges Bank owned apprApril 7, 2025 | marketbeat.comKrystal Biotech: Some Uncertainty, Some ValueApril 6, 2025 | seekingalpha.comQ3 EPS Estimates for Krystal Biotech Lifted by William BlairKrystal Biotech, Inc. (NASDAQ:KRYS - Free Report) - Equities research analysts at William Blair increased their Q3 2025 earnings estimates for Krystal Biotech in a note issued to investors on Wednesday, April 2nd. William Blair analyst S. Corwin now anticipates that the company will post earningsApril 6, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by Sei Investments Co.Sei Investments Co. trimmed its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 38.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 21,164 shares of the company's stockApril 5, 2025 | marketbeat.comBlair William & Co. IL Buys 1,875 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Blair William & Co. IL grew its stake in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 33.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,443 shares of the company's stock after buying an additional 1,875 sApril 4, 2025 | marketbeat.comWilliam Blair Keeps Their Buy Rating on Krystal Biotech (KRYS)April 3, 2025 | markets.businessinsider.comPictet Asset Management Holding SA Sells 3,261 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Pictet Asset Management Holding SA lowered its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 2.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 112,089 shares of the company'sApril 3, 2025 | marketbeat.comVanguard Group Inc. Increases Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS)Vanguard Group Inc. grew its stake in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 1.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 2,878,451 shares of the company's stock after acquiring an additional 28,707 shares during the period. VangApril 3, 2025 | marketbeat.com4,300 Shares in Krystal Biotech, Inc. (NASDAQ:KRYS) Bought by KLP Kapitalforvaltning ASKLP Kapitalforvaltning AS acquired a new stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,300 shares of the companyApril 3, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Shares Bought by Prudential Financial Inc.Prudential Financial Inc. raised its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 8.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 41,193 shares of the company's stock afApril 1, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Shares Bought by Teacher Retirement System of TexasTeacher Retirement System of Texas grew its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 27.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 6,383 shares of the company's stock after purchasing an additionalMarch 30, 2025 | marketbeat.comEFG Asset Management North America Corp. Has $2.78 Million Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)EFG Asset Management North America Corp. grew its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 30.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 17,714 shares of the company's stock after purchaMarch 27, 2025 | marketbeat.comFox Run Management L.L.C. Invests $339,000 in Krystal Biotech, Inc. (NASDAQ:KRYS)Fox Run Management L.L.C. bought a new stake in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 2,161 shares of the company's stock, valued at approximately $339,000March 27, 2025 | marketbeat.comSegall Bryant & Hamill LLC Has $23.39 Million Position in Krystal Biotech, Inc. (NASDAQ:KRYS)Segall Bryant & Hamill LLC cut its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 5.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 149,309 shares of theMarch 26, 2025 | marketbeat.comSummit Global Investments Acquires New Shares in Krystal Biotech, Inc. (NASDAQ:KRYS)Summit Global Investments bought a new stake in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 3,453 shares of the company's stock, valued at approximaMarch 25, 2025 | marketbeat.comCibc World Markets Corp Invests $364,000 in Krystal Biotech, Inc. (NASDAQ:KRYS)Cibc World Markets Corp acquired a new stake in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 2,321 shares of the company's stock, valued at approximately $364,000. SMarch 25, 2025 | marketbeat.comStocks Showing Improving Market Leadership: Metsera Earns 82 RS RatingMarch 24, 2025 | msn.comSwiss National Bank Increases Stock Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)Swiss National Bank grew its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 8.4% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 42,400 shares of the company's stock after purchasing an additionalMarch 23, 2025 | marketbeat.comCorient Private Wealth LLC Reduces Stake in Krystal Biotech, Inc. (NASDAQ:KRYS)Corient Private Wealth LLC cut its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 9.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 43,009 shares of the company's stock after selling 4,678 shares during the period. CorMarch 22, 2025 | marketbeat.comZurcher Kantonalbank Zurich Cantonalbank Raises Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 31.2% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 6,054 shares of the company's stock after acquiring an additional 1,44March 21, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Short Interest Down 13.5% in FebruaryKrystal Biotech, Inc. (NASDAQ:KRYS - Get Free Report) saw a large decline in short interest during the month of February. As of February 28th, there was short interest totalling 2,760,000 shares, a decline of 13.5% from the February 13th total of 3,190,000 shares. Currently, 11.2% of the company's stock are short sold. Based on an average daily trading volume, of 278,600 shares, the short-interest ratio is currently 9.9 days.March 20, 2025 | marketbeat.comPrivium Fund Management B.V. Buys 2,900 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Privium Fund Management B.V. boosted its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 45.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 9,250 shares of the company's stockMarch 20, 2025 | marketbeat.comHarrow Shows Market Leadership With Jump To 92 RS RatingMarch 19, 2025 | msn.comRaymond James Financial Inc. Takes $15.99 Million Position in Krystal Biotech, Inc. (NASDAQ:KRYS)Raymond James Financial Inc. bought a new stake in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 102,061 shares of the company's stock, valued at approximately $15,989,000. RaymonMarch 19, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Receives Average Rating of "Buy" from AnalystsKrystal Biotech, Inc. (NASDAQ:KRYS - Get Free Report) has been given an average rating of "Buy" by the eight brokerages that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a hold rating, six have given a buy rating and one has issued a stronMarch 17, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by Skandinaviska Enskilda Banken AB publSkandinaviska Enskilda Banken AB publ lowered its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 29.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 89,047 shares of the company's stock after selling 37,035 shares duringMarch 16, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Position Increased by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. lifted its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 1.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 243,170 shareMarch 16, 2025 | marketbeat.comInsider Selling: Krystal Biotech, Inc. (NASDAQ:KRYS) Insider Sells 25,000 Shares of StockKrystal Biotech, Inc. (NASDAQ:KRYS - Get Free Report) insider Suma Krishnan sold 25,000 shares of the firm's stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $177.79, for a total value of $4,444,750.00. Following the sale, the insider now owns 1,463,711 shares in the company, valued at approximately $260,233,178.69. The trade was a 1.68 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.March 14, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Stock Position Lifted by AlphaQuest LLCAlphaQuest LLC lifted its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 116.0% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,020 shares of the company's stock after purchasing an additional 1,622 shareMarch 13, 2025 | marketbeat.comVictory Capital Management Inc. Reduces Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS)Victory Capital Management Inc. cut its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 17.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 81,328 shares of the company's stock after sMarch 13, 2025 | marketbeat.comWilliam Blair Sticks to Their Hold Rating for Legend Biotech (LEGN)March 12, 2025 | markets.businessinsider.comBank of New York Mellon Corp Has $26.53 Million Position in Krystal Biotech, Inc. (NASDAQ:KRYS)Bank of New York Mellon Corp lessened its position in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 1.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 169,346 shares of the company's stock after selling 2,307 shares during theMarch 10, 2025 | marketbeat.comEdgestream Partners L.P. Sells 8,447 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)Edgestream Partners L.P. lessened its position in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 26.2% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 23,810 shares of the company's stock after selling 8,447 shares during the period. Edgestream PartMarch 9, 2025 | marketbeat.com Remove Ads Get Krystal Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for KRYS and its competitors with MarketBeat's FREE daily newsletter. Email Address KRYS Media Mentions By Week KRYS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KRYS News Sentiment▼0.790.86▲Average Medical News Sentiment KRYS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KRYS Articles This Week▼166▲KRYS Articles Average Week Remove Ads Get Krystal Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for KRYS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TEVA News ITCI News SMMT News GMAB News RDY News MRNA News VTRS News QGEN News ASND News ROIV News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KRYS) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Krystal Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Krystal Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KRYS Stock Free KRYS Stock Alerts